1.1

The goal:

1a. Systemic destruction of pathogens by selective disruption of key metabolic pathways, unique to invading organism.

1b. Deactivation of harmful molecular products and/or metabolic process's caused by deviant cellular activity. I.E. Cancer, Auto-immune Conditions, Poisons, Aging, etc.

1.2

The methodology:

The Bio-Molecular Resonance Generator (BMRG) delivers a complex electromagnetic waveform throughout the human body, causing selective resonant absorption of energy by the targeted molecule(s).  This absorption of energy results in conformational disruption (denaturing) of the targeted molecule(s).  The targeted molecule(s) would include enzymes and other proteins unique to the invading organism.  In this context, the term "invading organism" would include viruses, bacteria, amoebas, spirochetes, etc.  AIDS (HIV), Ebola, Hunta, Dengue, Plague, Cholera, Polio, Strep, Pneumonia, Staph, Anthrax, Avian influenza (H5N1), and Syphilis are some examples of the wide spectrum of viruses and micro-organisms to which this process is applicable.  The process is non-invasive and since molecular resonance is targeted, will result in minimal damage to normal cellular activity.  In addition to destroying viruses and pathological micro-organisms, BMRG technology will be able to destroy cancer cells, and correct the function of defective enzymes allowing a return to health for the sick and dying.  Another use is stimulating the controlled release of toxic substances from the tissues of environmental illness victims.

1.3

The procedure:

BMRG operation can be divided into 4 separate phases.

1.3.1

Diagnostic phase:

BMRG is used to perform a JTFA chirp resonance scan of the patient.  The results of the scan are then compared to a library of known pathogen and/or abnormal metabolic process signatures.  The comparison process utilizes a fuzzy logic algorithm to locate most probable matches and the results are displayed, ranked by degree or likelihood of match.

1.3.2

Pre-treatment phase:

Based on the results of the BMRG diagnostic phase, and/or any conventional diagnostic indicators available to the attending physician, a treatment modality is selected.  Factors that will influence treatment modality would include virulence of pathogen, genetic deviance of pathogen from nominal baseline, collateral and/or patient specific risk factors such as kidney or liver toxin clearing capacity, and immune system competency.  Once a treatment modality is determined, the BMRG constructs a waveform, using inverse Fourier transform techniques, that selectively targets those molecule(s) most specific and/or critical to the disease complex.

1.3.3

Treatment phase:

The waveform constructed during pre-treatment phase (1.3.2) is used to irradiate the patient.  The form of radiation used is strictly electromagnetic in nature, and is applied in such a manner and duration as to supply sufficient energy to bring about the conformational disruption (denaturing) of the targeted molecular species.  The result derived from conformational disruption is dependent on the exact nature of the disease and is discussed in depth under the topic of disease specific treatment strategies (see 5 below).

1.3.4

Assay phase (post treatment examination):

The BMRG is used to perform one or more post treatment assays of efficacy.  Again, a JTFA chirp resonance scan is performed to determine the degree of disease complex disruption and recovery prognosis.  If indicated, treatment modality may be modified and/or further treatment/assay cycles administered until the desired result is achieved.

1.4

Background, and theory of operation:

All living organisms are critically dependent on proteins to perform task specific, chemical transformations required for continued metabolic function.  These proteins consist of polymerized (peptide bonded) chains of amino acids, assembled under the direction of the host DNA.  In most cases, the specific chemical activity of a protein is not a primary or secondary function of the amino acid sequence, but rather a tertiary result, caused by the geometric folding of the protein, or even a quaternary result, caused by the geometric complexing of several separate protein components.  While the protein it self is composed of covalent bonds, the folding geometry is determined by the weaker Van der Waals forces and/or so called hydrogen bonding.  It is the unequal electric charge distribution, as created by the specific amino acid sequence, combined with the immediate chemical/molecular environment, that determines the geometric folding of a specific protein, and hence it's specific chemical activity.  The molecular weight of most proteins range from thousands, to millions of Daltons. (one Dalton is equivalent to the weight of one hydrogen atom)

Therefore, protein activity can be summarized as follows:

Massive linear molecules with unequal electric charge distribution, spontaneously fold into biologically active, minimum energy forms, by a combination of internal charge distribution and local environment.  In the context of this discussion, the key phrases are "unequal electric charge distribution", and "minimum energy forms".

We could visualize a physical model of the protein, as a set of massive, rod shaped weights, connected to each other by hinges, and folded together by a series of weak interconnecting springs.  This model would be subject to disruption of it's folding geometry by the application of small cyclic or repetitive forces that are in resonance with the combination of masses and springs.  Since the system is being "pumped" at resonance, the forces acting on the system, constructively add or sum over time, and will eventually lead to conformational disruption of the geometric folding.  In the context of a protein, this conformational disruption will result in the cessation of normal biological activity.

Through the process of electromagnetic resonance, specifically targeted at selected proteins, and acting on the unequal charge distribution present in every protein, the BMRG is designed to bring about conformational disruption of the protein folding pattern in the targeted protein(s).  In other words, by pumping energy into a protein, through the process of electromagnetic resonate coupling, the molecule is raised from it's minimum energy geometry (folded) form, and thereby rendered biologically inactive.

1.5

Disease specific treatment strategies:

The diseases suitable to treatment by the BMRG process fall into four broad categories.  While all four categories make use of the molecular resonance principle, each category requires different treatment modalities and protocols.

1.5.1

Infectious diseases:

All infectious diseases, whether bacterial, viral, or protozoan in nature, produce a unique or disease specific set of proteins as part of the infection process.  These proteins can be detected and selectively targeted for disruption by the BMRG.  Once disrupted, the replication process of the infecting agent will no longer be able to sustain the disease condition.  Unlike conventional antibiotics, the BMRG can disrupt a wide spectrum of proteins created by the infecting agent.  Therefore the development of resistant mutations by the infecting agent is rendered almost impossible.  Further, since both the diagnostic and treating agents are electromagnetic in nature, development of treatment protocols for new pathogens is reduced from years, to a matter of weeks or even days.

1.5.2

Cancer:

The underlying cause of cancer is the inability of a natural cellular population to properly control replication.  In all cases, the replication process is mediated by a cascade of so called messenger molecules, many of which are proteins.  Cancer results from a defective step somewhere in the cascade.  Therefore, while the underlying cause is genetic, the actual operative agents are the abnormal messenger molecules.  These abnormal molecules can be detected and selectively disrupted by the BMRG.  Once the replication process is disrupted, the population of cancer cells may be cleared from the body, either by conventional methods, or by further application of the BMRG, targeting molecules involved with normal cellular metabolism of the cancer cell population.  This method is analogous to chemotherapy.  However, unlike chemotherapy, the BMRG treatment can be focused to minimize collateral metabolic damage.

1.5.3

Auto-immune diseases:

Under normal conditions, the immune system is inhibited from attacking the molecular components of the body.  There are several mechanisms involved in this control of the immune system.  One mechanism is clone deletion, whereby populations of immune cells that recognize (react to) normal molecular products found in the organism self-destruct (are deleted).  Another mechanism is the modulation of immune response by hormones secreted by the immune system, and other regulatory glands.  Regardless of the mechanism, when the immune system becomes sensitized to, and reacts with, some naturally occurring molecular component of the organism, an auto-immune disease condition results.  The auto-immune disease is self reinforcing, because the aberrant reaction causes the immune system to produce further quantities of the reacting clone, and these in turn support further reaction in an endless cycle.  The BMRG may be used to both identify the aberrant clone population, and to bring about the selective disruption of that clone population.  This is possible because each clone population has unique marker proteins imbedded in it's cell membrane.  It is these marker proteins that interact with the molecular components of pathogens, as well as naturally occurring molecular components, thereby triggering the auto-immune response, and if these proteins are selectively disrupted, the aberrant response will abate.

1.5.4

Toxic poisoning:

In modern industrial society, the human body is exposed to many substances that are harmful or disruptive to proper metabolic functioning.  Some of these substances are unique, in as much as they do not occur in nature (dioxin for instance).  Others, while natural, are concentrated by industry to levels far in excess of those found in nature (lead in paint for instance).  Regardless of the synthetic or natural poison, disease results when the substance accumulates in the tissues of the body, and causes impairment or disruption of normal metabolic activity.  Implicit in the accumulation of these toxic substances in the body, is the complexing, or chemical interaction of the poison with molecules normally found in the organism.  This has two consequences.  First, it interferes with the normal functioning of the molecule, leading to the disease state.  Second, it renders the poison intractable to the normal mechanisms that are responsible for clearing toxins from the organism.  Both heavy metals, and fat soluble toxins are particularly pernicious in this respect.  Again, the BMRG may be used both to identify the toxin complex, and through resonance, to disrupt the chemical complexing or bonding of the toxin with the molecules normally found in the body.  However, this must be done slowly, in a controlled manner.  Otherwise, toxic shock caused by the rapid liberation of large quantities of poison into the blood will occur , with the resultant potential for kidney and/or liver failure.

1.6

Anti-Aging:

Although an exact and complete description for the causes of aging remain an elusive goal.  Many of the processes have been uncovered in recent years.  Among these are the accumulation of defective proteins, caused either by improper genetic coding or environmental damage (1.5.4).  These aberrant proteins lead to impaired or improper functioning of body processes, and in turn, leads to further creation and/or accumulation of aberrant proteins.  This positive re-enforcement of accumulated errors in protein functioning is the primary cause for the rapid (almost geometric) decline of health, observed in the later years of life.  The BMRG can be used to curtail this positive re-enforcement of protein aberrations through repeated routine treatments.  It is my opinion that such treatments, when coupled with the removal of toxins, and pathogens, along with the suppression of incipient cancers, should lead to a condition of slow, linear aging, as opposed to the rapid, geometric aging curve observed in current human populations.  Further, I speculate that useful life spans in excess of 200 years may be possible, when these techniques are fully understood and implemented.

End

Bio-Molecular Resonance Generator (BMRG)